AZ selects ImpactRx to check effectiveness

Share this article:
AstraZeneca named ImpactRx to work on measuring the effectiveness of its sales force teams promoting the products Crestor, Nexium and Seroquel to primary care and specialty physicians. ImpactRx measures sales force effectiveness along three dimensions: how sales representatives
execute their plan of action; how well physicians perceive their efforts; and the impact of their activities on new patient treatment decisions.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.